1Vladimir MIHAL, The Analysis of Correlations between Drug Resistanceand Clinical/Laboratory Measures Found in a Group of Children with ALL Treated by ALL-BFM 90 Protocol. Electronic Journal of Ontology, 1999; 1, 80-89.
2PuiC-H. Childhood leukemias. N Engl J Med 1995 ;332 : 1618-30.
9Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.
10Allen R. Chauvenet, Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia ofcbildhood: a report from Children' s Oncology Group Study 179201. BLOOD, 15 AUGUST 2007 VOLUME 110, NUMBER 4, 1105-1112.
6Pui CH,Sandlund JT,Pei D,et al.Improved outcome for children with acute lymphoblastic leukemia:results of total therapy studyX ⅢB at St Jude children's Research Hospital[J].Blood,2004,104(9):2690-2696.
7Pui CH,Relling MV,Sanglund JT,et al.Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia[J].Ann Hematol,2004,83:124-126.
8Silverman LB,Gelber RD,Dalton VK,et al.Improve outcome for children with acute lymphoblastic leukemia:results of Dana-Farber Consortium protocol 91-01.Blood,2001,97 (5):1211-1218.
10Rubnitz JE,Link MP,Shuster JJ,et al.Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia:A Pediatric Oncology Group study[J].Blood,1994,84(2):570-573.
7Basu D, Siddaraju N, Murugan P, et al. Cytologic aspects of T-cell acute lymphoblastic leukemia presenting as a massive pericardial effusion: a case report[J]. Acta Cytol, 2009, 53(3) : 337 -340.
8Arat N, Bakanay S M, Yildiz E, et al. Complete regression of massive cardiac involvement associated with acute T cell leukemia following chemotheraphy[ J]. Eur J Echocardiogr, 2008, 9 (3) : 388 - 390.
9Chaves F P, Quillen K, Xu D. Perieardial effusion : a rare presentation of adult T-cell leukemia/lymphoma [J]. Am J Hematol, 2004, 77 (4) : 381 -383.
